... In a recent review, Dharmawansa, Hoskin, and Rupasinghe (2020) summarized the differences between anthocyanin-induced effects in normal and cancer cells. While in normal cells anthocyanins mediate processes, that contribute to cancer prevention, including antioxidant defence (via ROS scavenging, activation of glutathione antioxidant system and Nrf2 pathway) and reduction in the formation of oxidative DNA adducts (Amararathna, Hoskin, & Rupasinghe, 2020;Ferrari et al., 2016;Shih, Yeh, & Yen, 2007), suppression of inflammatory responses via downregulation of NF-κB and AP-1 signaling pathways (Ferrari et al., 2016;Jang, Lee, Choi, & Yim, 2020;Limtrakul, Yodkeeree, Pitchakarn, & Punfa, 2015), in cancer cells anthocyanins can induce DNA damages (via modulation the activity of DNA topoisomerases I and II) (Habermeyer et al., 2005), inhibit cell growth and proliferation (via modulation of MAPK, NF-κB, AMPK, insulin/IGF-1, and Wnt/β-catenin pathways) (Kim, Shin, & Park, 2005;Klein & Fischer, 2002;Vendrame & Klimis-Zacas, 2015;Wang, DeGroff, & Clinton, 2003;Wei et al., 2020;Yun-Kyoung, Park, Kim, Lee, & Park, 2010) and induce apoptosis (via mitochondrial pathway and activation of caspase-9) (Yun, Afaq, Khan, & Mukhtar, 2009). ...